Insider Transactions in Q4 2022 at Novo Cure LTD (NVCR)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2022
|
Ashley Cordova Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.62%
|
$14,000
$7.15 P/Share
|
|
Nov 01
2022
|
Frank X Leonard EVP, Pres., Novocure Oncology |
BUY
Grant, award, or other acquisition
|
Direct |
6,830
+11.92%
|
-
|
|
Oct 13
2022
|
Frank X Leonard EVP, Pres., Novocure Oncology |
SELL
Open market or private sale
|
Direct |
6,754
-13.41%
|
$513,304
$76.01 P/Share
|
|
Oct 06
2022
|
Frank X Leonard EVP, Pres., Novocure Oncology |
SELL
Open market or private sale
|
Direct |
6,754
-11.82%
|
$567,336
$84.37 P/Share
|